Enzymes are biological catalysts that drive nearly all biochemical reactions in living organisms. They play crucial roles in metabolic pathways, cellular signaling, and even DNA replication. As such, there is a relentless quest within the scientific community to improve these natural catalysts for various applications, including pharmaceuticals, biotechnology, and environmental science. However, conventional approaches to enzyme engineering often fall short, particularly when it comes to complex eukaryotic systems.

One of the primary challenges in enzyme engineering is the proper folding of proteins after synthesis. When proteins are expressed, they often do not fold into their functional structures, leading to inactive or insoluble products. This issue is exacerbated in eukaryotic enzymes due to their intricate folding pathways and post-translational modifications. The study by Tang and colleagues proposes an elegant solution through the development of an in situ refolding technology that allows for the direct and efficient conversion of misfolded enzymes back into their active forms.

This novel refolding technology capitalizes on an approach that merges the principles of molecular biology with physical chemistry to facilitate proper protein folding. By employing optimized refolding buffers, specific chaperones, and co-factors, the researchers created an environment conducive to the recovery of enzyme functionality. This method not only enhances the yield of active enzymes but also significantly reduces the time and resources needed for enzyme production.

In the study, the authors meticulously outline their experimental procedures, detailing how they adapted existing refolding protocols for eukaryotic enzymes. They highlight that this in situ refolding technology can be integrated into various expression systems, making it highly versatile. The ability to produce functional enzymes from eukaryotic organisms, which are often preferred for their complex structures and functionalities, opens new avenues for research and practical applications.

One of the standout features of this in situ refolding technology is its potential for high-throughput screening. By allowing accelerated testing of enzyme variants, scientists can quickly identify candidates with desirable traits for further development. The researchers utilized a directed evolution approach, where random mutations are introduced into the enzyme’s gene, and the resultant variants are screened for improved performance. This synergy between in situ refolding and directed evolution could expedite the discovery of enzymes that outperform their wild-type counterparts.

Moreover, the implications of this technology extend beyond mere enzyme production. Enzymes engineered through this method could have far-reaching impacts in industrial applications, including biofuel production, waste treatment, and synthetic biology. The capacity to create bespoke enzymes capable of catalyzing specific reactions lays the groundwork for environmentally friendly alternatives to traditional chemical processes.

The authors also discuss the practical aspects of implementing this technology in laboratory and industrial settings. They emphasize the importance of scalability, as the enzyme industry continues to grow at an unprecedented rate. The in situ refolding technology not only addresses the bottlenecks associated with enzyme production but also ensures that the enzymes produced are tailored for efficiency and efficacy.

In terms of sustainability, the ability to engineer enzymes for specific tasks aligns perfectly with current global challenges. Industries are facing increasing pressure to reduce their environmental footprint, and enzymes offer a path toward greener alternatives. Through the advances described in this research, better biocatalysts can be developed, thereby enabling more efficient and less polluting chemical processes.

Future research stemming from this study could explore the applications of in situ refolding technology in various biological systems, including plants and microorganisms, which could lead to the discovery of novel enzymes not previously accessible through traditional methods. The scalable nature of this technology paves the way for biotechnological innovations previously thought out of reach, making it a cornerstone of future enzyme research.

In summary, the revolutionary work by Tang and colleagues propels the field of enzyme engineering into a new era. Their in situ refolding technology not only enhances our ability to produce active enzymes from eukaryotic sources but also sets the stage for significant advancements in directed evolution strategies. This research epitomizes the fusion of science and practicality, addressing critical challenges faced by researchers and industries alike.

As this research gains attention, it is poised to inspire further investigations into protein folding solutions, enzymatic efficiency, and environmentally conscious practices across various sectors. The concerted efforts in the scientific community to unlock the full potential of enzymes reveal a promising horizon for biochemistry, biotechnology, and beyond.

This breakthrough encourages an optimistic view of the future, where enzyme engineering will not only provide answers to existing problems but will also uncover new possibilities that we have yet to envision, ultimately enhancing our capacity to tackle pressing global issues.

Subject of Research: Innovation in enzyme engineering through in situ refolding technology for eukaryotic enzymes.

Article Title: Development of in situ refolding technology for directed evolution of enzymes from eukaryotes.

Article References:
Tang, Z., Huang, X., Wen, J. et al. Development of in situ refolding technology for directed evolution of enzymes from eukaryotes. 3 Biotech 16, 86 (2026). https://doi.org/10.1007/s13205-026-04693-3

Image Credits: AI Generated

DOI: https://doi.org/10.1007/s13205-026-04693-3

Keywords: enzyme engineering, directed evolution, in situ refolding, eukaryotic enzymes, biotechnology, protein folding, biocatalysis, sustainability.

Despite their broad functional importance, the behavior of biological nanopores remains partly enigmatic, especially concerning the mechanisms driving ion transport through them. Ion flow in these nanopores exhibits complex patterns that scientists have not yet entirely deciphered. Two phenomena, in particular, have posed significant challenges: rectification and gating. Rectification describes the scenario where ion transport varies depending on the polarity of the applied voltage, effectively making the ion flow asymmetric. Gating, on the other hand, refers to abrupt reductions or stoppages in ion flow, potentially compromising the stability and reliability of nanopore-based sensing technologies.

A major breakthrough addressing these enigmas has emerged from a collaborative research team led by Matteo Dal Peraro and Aleksandra Radenovic at EPFL. Incorporating a multidisciplinary approach that blends experiments, computational modeling, and theoretical frameworks, their work meticulously unravels the fundamental principles dictating the rectification and gating behaviors in biological nanopores. This research not only sheds light on the biophysical underpinnings of these phenomena but also paves the way for enhanced design strategies in nanopore technologies.

The team centered their investigations on aerolysin, a β-barrel pore-forming protein derived from bacteria, which has found extensive use in molecular sensing due to its reliable ion channel properties. Through precision genetic engineering techniques, the researchers systematically introduced mutations to charged amino acids lining the inner surface of the nanopore. These mutations generated an extensive library of 26 unique nanopore variants, each exhibiting distinct electrical charge distributions. Comprehensive ionic current measurements through these variant nanopores under diverse voltage conditions then provided unprecedented insights into how specific charge patterns influence ion transport dynamics.

A novel aspect of the study was the use of alternating voltage signals to probe the nanopores at varying timescales. This methodological innovation enabled the researchers to temporally segregate rectification phenomena, manifesting at shorter timescales, from the more temporally extended gating events. By overlaying biophysical models with empirical data, the team constructed a robust theoretical scaffold that explains the coupling between ionic currents and nanopore structural responses—elucidating how charge localization governs the complex ion transport behaviors.

Delving into rectification, the study reveals that the distribution of electrical charges molded along the lumen of the nanopore significantly biases ion transport directionality. This intrinsic asymmetry in charge arrangement functions akin to an ionic diode or one-way valve, facilitating greater ion passage in one direction over the other. Such rectified ion flows, dictated by the electrostatic landscape, have vital implications for the sensitivity and selectivity of nanopore sensors and for the fundamental understanding of biological ion channels.

Regarding gating, the findings indicate that sustained high ionic flow can induce localized charge imbalances within the pore mouth, resulting in structural destabilization. This destabilization causes partial collapse or constriction of the nanopore architecture, transiently obstructing ion flow. Importantly, the propensity for gating is not merely dependent on the total charge but intrinsically linked to the exact spatial positioning and polarity of these charges. The research demonstrates that by altering the charge “sign” at specific sites, one can finely tune the nanopore’s gating threshold and conditions, thus redefining the operational stability of these biological conduits.

Complementary experiments also show that reinforcing the structural rigidity of the nanopore abrogates gating behavior entirely. This crucial observation underscores the mechanical flexibility of the pore as a key modulator of gating, shifting the narrative from purely electrostatic considerations to a mechanochemical interplay in ion channel regulation. Such insights open new avenues for engineering nanopores with tailored mechanical properties to either prevent undesirable gating or exploit it for specialized applications.

The implications of these findings extend beyond incremental engineering improvements. The researchers have successfully demonstrated the potential to create nanopores that emulate synaptic plasticity—the brain’s ability to modulate synaptic strength in response to stimuli. By designing nanopores that “learn” from voltage pulses, the team pioneers a bio-inspired computing paradigm that leverages ion flow dynamics for information processing. This revolutionary concept portrays nanopores not just as static sensors but as active components capable of adaptive, memory-like behavior, potentially transforming approaches to neuromorphic computing and ion-based processors.

Exploring the practical applications, this research equips molecular engineers with the knowledge to intentionally circumvent gating in nanopore sensing platforms, thereby enhancing signal stability and measurement accuracy. Conversely, by strategically harnessing gating phenomena, novel classes of ionic devices capable of memory and logic functions can be realized. This dual capability marks a significant leap in the interface between biological nanostructures and advanced computational systems, fostering innovation in biomimetic device architecture.

Supporting institutions involved in this multidisciplinary study include the Institute of Science and Technology Austria, University of Washington, and ENS de Lyon, each contributing expertise critical to experimental design, computational modeling, and theoretical analysis. Their collaboration underscores the global and integrative nature of cutting-edge nanopore research.

The intricacy of ion transport in biological nanopores, long a subject of debate, now rests on a clearer physical foundation thanks to this pioneering work. Through elegant integration of mutation-driven charge reorganization, high-resolution ionic measurements, and theoretical modeling, the diverse and previously mystifying behaviors of nanopores have been coherently demystified. This advancement not only augments the fundamental biophysics of membrane channels but also catalyzes new frontiers in biotechnology, from next-generation DNA sequencers to bio-inspired computing devices.

As nanopore technologies continue their ascent in scientific and technological importance, these insights provide indispensable guidelines for crafting bespoke nanopores with optimized functionalities. The ability to modulate ion transport with such precision embodies a transformative stride toward the full exploitation of biological pores, propelling both our understanding and utilization of nature’s nanoscale machinery.

Subject of Research: Ion transport mechanisms in β-barrel biological nanopores and their biophysical modulation.

Article Title: Lumen charge governs gated ion transport in β-barrel nanopores.

News Publication Date: 11-Nov-2025

Web References:
https://doi.org/10.1038/s41565-025-02052-6

Image Credits: Aleksandra Radenovic/EPFL

Keywords: Biological nanopores, ion transport, ion gating, rectification, aerolysin, β-barrel pore, nanopore sensing, synaptic plasticity mimicry, bio-inspired computing, molecular transport, nanobiophysics.

The most extensively studied variant of this system is CRISPR-Cas9. In this robust mechanism, bacteria can capitalize on their genetic memories by transcribing the stored viral DNA into RNA sequences. These RNA sequences serve as guides to direct the Cas9 protein, a molecular scalpel that locates and cuts the DNA of invading phages during subsequent infections. The cutting process initiated by Cas9 requires a short DNA sequence known as the Protospacer Adjacent Motif, or PAM, acting as a recognition signal for the protein to locate the site to make its incision. The implications of these findings have widespread applications, notably in gene editing, where CRISPR is utilized to modify various organisms, including plants, animals, and human cells, thereby opening new avenues for gene therapies and treatments.

Despite the progress made with CRISPR-Cas9, critical questions remained concerning how bacteria generate these essential immune memories. Understanding the intricate process of memory acquisition within the CRISPR system constitutes a key challenge for scientists. Recently, efforts from a research group under the guidance of Dr. Yan Zhang at the University of Michigan have shed light on this enigma, particularly focusing on redefining the role of Cas9 when it operates in its unbound or “empty” state, referred to as apoCas9. This research brings forth an intriguing paradigm shift in our understanding of CRISPR-Cas9.

Previous investigations had primarily concentrated on the Type II-A systems of bacteria like Streptococcus pyogenes and Streptococcus thermophilus. These studies elucidated how Cas9 collaborates with its RNA partners, particularly tracrRNA, to effectively facilitate memory acquisition. However, the Type II-C systems, which encompass more than 40% of Cas9 variants, remained less understood until Zhang’s team embarked on their innovative study using Neisseria meningitidis, a bacterium associated with potential meningitis infections. This team aimed to scrutinize whether the bacterium could develop new immune memories, exploring various manipulations to its systemic machinery.

The initial hypothesis revolved around the assumption that Cas9 requires its RNA partners to facilitate memory formation. Nonetheless, findings from this research group brought unexpected results. Utilizing advanced sequencing technologies, the team observed that, following phage infections, Cas9 demonstrated a significant capacity to acquire new spacer sequences that encode memories of these viral encounters. Most strikingly, upon deleting the tracrRNA gene—part of the conventional understanding of RNA’s role—the team observed a marked increase in the acquisition of spacer sequences, highlighting an unanticipated mechanism within the CRISPR framework.

Upon restoration of tracrRNA, however, the increased rate of memory acquisition retracted to baseline levels, suggesting a regulatory effect emanating from this RNA component. Additionally, further analysis involving crRNA yielded similar results. The absence of crRNA led to dramatic enhancements in memory acquisition, while reintroducing this RNA resulted in a decrease in such activity. This paradox between the traditionally recognized role of RNA and the new evidence supporting apoCas9 as a functional entity underscores a potentially profound aspect of CRISPR systems.

The implications of this revelation extend to the understanding of how bacterial immune systems dynamically adjust. When the levels of CRISPR RNA are low—which suggests an impoverished memory landscape—apoCas9 can escape the constraints imposed by its RNA partners. In this “freed” state, apoCas9 can significantly boost the acquisition of new spacers, enhancing the bacteria’s ability to protect itself amid potential phage assaults. This research suggests a robust mechanism by which bacterial organisms ensure the resilience of their immune memory banks, promoting adaptability in ever-evolving environments rife with viral threats.

The study also delineated three scenarios wherein bacteria might experience abbreviated CRISPR arrays, leading to diminished immune memories. The first scenario involves nascent CRISPR arrays that are newly formed and have yet to accumulate sufficient spacer content. In such instances, Cas9 would predominantly exist in its apo form, actively seeking to stabilize the array by acquiring new spacer sequences. The second and third scenarios involve more complex dynamics, where existing CRISPR arrays collapse into shorter forms. Both phenomena can either be a mechanism for shedding undesirable or harmful memories—a bid to acquire new traits—or a consequence of homologous recombination that erases memories inadvertently during genetic exchanges.

By expanding the known functions of Cas9 and elucidating the mechanisms underlying memory acquisition, this study represents a monumental advance in molecular genetics. It bridges existing knowledge gaps and enhances our comprehension of CRISPR-Cas9 systems, offering insight into the dynamic equilibrium bacteria maintain within their immune memory. Such understanding can catalyze the development of improved gene editing technologies, molecular recording systems, and pioneering applications in precision medicine.

As the research progresses, the ability to manipulate cellular mechanisms such as memory acquisition could lead to groundbreaking innovations in various fields. The new findings position researchers to establish bespoke CRISPR-based tools that cater to specific needs—whether in medical research, genetic profiling, or biotechnological advancements. The CRISPR-Cas9 system continues to evolve, showcasing nature’s ingenuity in the face of biological challenges posed by microbial adversaries.

With this revelation about the innate flexibility of Cas9’s function, the scientific community is presented with a vital opportunity to redefine approaches toward gene editing and genetic memory management. Further investigation into these mechanisms will undoubtedly yield additional insights and technologies, underscoring the remarkable potential of CRISPR systems to transform life sciences fundamentally.

Subject of Research: Memory Acquisition in the CRISPR-Cas9 System
Article Title: Cas9 senses CRISPR RNA abundance to regulate CRISPR spacer acquisition
News Publication Date: [Insert Date]
Web References: [Insert References]
References: [Insert References]
Image Credits: [Insert Credits]

Keywords

The innovative AI tool developed by the CRG researchers is adept at creating DNA regulatory sequences that are not naturally occurring. This tool allows scientists to specify criteria for DNA fragments, leading to precise alterations in gene expression. For instance, researchers can instruct the AI to fabricate DNA sequences targeted specifically for stem cells, guiding them to differentiate into red blood cells while avoiding the formation of platelets. This level of specificity in genetic manipulation was previously unattainable, showcasing the immense potential of this technology.

One of the notable aspects of this study is the methodical approach taken by the researchers. By predicting the requisite combination of DNA nucleotides – adenine (A), thymine (T), cytosine (C), and guanine (G) – the model can generate synthetic fragments that meet the desired gene expression patterns for designated cell types. Following the design process, the researchers chemically synthesized roughly 250-nucleotide long DNA fragments, which were subsequently delivered to cells using viral vectors. This methodology yielded successful outcomes, validating the predictive capabilities of the AI model.

In a proof-of-concept experiment, the researchers tasked the AI with generating synthetic sequences that would activate a gene responsible for producing a fluorescent protein. This was achieved while ensuring the surrounding gene expression patterns remained unchanged. The fragments were introduced into mouse blood cells, resulting in successful integration of the genes into random locations within the genome, all aligning with the predictions made by the AI. Such precision exemplifies the transformative impact that AI can have on genetic research and therapy.

Dr. Robert Frömel, the first author of the study, emphasized the vast ramifications of this advancement, likening the process of designing genetic sequences to writing software for biological systems. This analogy captures the essence of the research, highlighting the potential for inducing specific cellular behaviors and developmental pathways with pinpoint accuracy. As gene therapy continues to evolve, the ability to finely tune gene expression could hold the key to enhancing treatment effectiveness while minimizing side effects, particularly in cells and tissues where adjustment is necessary.

Another significant aspect of this research is its contribution to understanding gene regulation and enhancer elements, small DNA fragments integral to controlling gene activity. Traditionally, geneticists have relied on naturally occurring enhancers, which can limit their options to sequences that evolution has already provided. In contrast, AI-generated enhancers possess the potential to engineer novel switching mechanisms that nature has yet to produce, enabling researchers to tailor gene expression patterns for specific therapeutic outcomes.

However, the successful development of such AI models necessitates access to high-quality data, which has historically been sparse for enhancers. To address this challenge, Dr. Lars Velten, the corresponding author of the study, explained the need for deciphering the “grammar” of enhancer sequences. By systematically investigating the nuances associated with enhancer functionality, researchers can begin to generate entirely new combinations of DNA sequences that could redefine our approach to genetic engineering.

Over the course of five years, the research team compiled an expansive dataset, synthesizing over 64,000 distinct synthetic enhancers. Each enhancer was meticulously designed to explore varying arrangements and strengths of binding sites for 38 different transcription factors, resulting in the largest library of synthetic enhancers created to date within blood cells. This ingenuity not only surpassed previous approaches but also provided a clearer insight into the mechanisms governing blood cell development and immune system functionality.

Upon inserting synthetic enhancers into cells, the researchers meticulously observed their activity across seven distinct stages of blood cell development. Unexpectedly, many enhancers were found to activate gene expression in specific cell types, yet functioned to repress gene activity in others. Such contrasting effects challenge conventional understandings of enhancer behavior and introduce novel concepts such as “negative synergy,” where two factors that typically induce gene activation together might actually suppress the gene when combined.

The experimental data generated from the research played a pivotal role in establishing the guiding principles for the AI-driven design model. As the model absorbed substantial metrics on enhancer-induced gene activity in real cellular contexts, it became proficient at predicting new sequences capable of producing on/off effects, even for sequences previously absent from the natural world. This predictive power of the AI marks a significant leap forward in the field and resonates with the aspirations to expand the horizons of genetic engineering.

The study ultimately serves as a testament to the potential of AI in biological research, illustrating that these technologies can address practical challenges in genetic modification before larger-scale implementation is pursued. The endeavor remains at the precipice of discovery, with human and mouse genomes containing an estimated 1,600 transcription factors that continue to be crucial in regulating gene expression.

As the researchers embark on further exploration, they are well-positioned to unlock new pathways in genetic therapy, offering an era where gene expression can be finely controlled to improve health outcomes. This work will likely catalyze future research endeavors, propelling innovation forward in both the fields of artificial intelligence and genetics, as scientists continue to seek remedies for complex diseases and genetic disorders.

The collective efforts of the research group, including notables like Lars Velten, Robert Frömel, Julia Rühle, Aina Bernal Martínez, Chelsea Szu-Tu, and Felix Pacheco Pastor, demonstrate how interdisciplinary collaboration can yield profound scientific advances. As the CRG team builds upon these findings, the implications of their work will reverberate through the scientific community, inspiring generations to come.

In conclusion, the marriage of AI and genetic engineering as showcased in this study not only represents a monumental shift in ability but also poses exciting possibilities for the future of medicine. As researchers grapple with the implications of their findings, the broader question remains: How can we harness this newfound power to address some of humanity’s most pressing health challenges?

Subject of Research: Cells
Article Title: Design principles of cell-state-specific enhancers in hematopoiesis
News Publication Date: 8-May-2025
Web References:
References:
Image Credits: Aina Bernal Martínez/Centro de Regulación Genómica

Keywords